The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice
- PMID: 1424285
- PMCID: PMC1554616
- DOI: 10.1111/j.1365-2249.1992.tb07940.x
The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice
Abstract
Antiphospholipid syndrome (APLS) is characterized by thrombocytopenia, thromboembolic phenomena and recurrent fetal loss, associated with anti-cardiolipin antibodies (ACA) and/or lupus anticoagulant. The syndrome may be primary or may be associated with other conditions such as systemic lupus erythematosus (SLE). In this study we induced primary APLS following immunization of BALB/c mice with a human monoclonal ACA (H-3). Analysis of the cytokine profile of the mice with experimental APLS indicated low production of IL-2, IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) by concanavalin A (Con A)-stimulated splenocytes of H-3 immunized mice. It seems that the low levels of IL-3 and GM-CSF have a potential role in the fetal loss of the APLS. Whatever the mechanism of IL-3 and GM-CSF in preventing fetal loss, these results may have therapeutic bearing on the reproductive outcome in women and other species with APLS.
Similar articles
-
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).J Clin Invest. 1992 May;89(5):1558-63. doi: 10.1172/JCI115749. J Clin Invest. 1992. PMID: 1569194 Free PMC article.
-
Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.J Autoimmun. 1992 Aug;5(4):495-509. doi: 10.1016/0896-8411(92)90008-e. J Autoimmun. 1992. PMID: 1418290
-
Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.J Clin Invest. 1993 Apr;91(4):1834-7. doi: 10.1172/JCI116396. J Clin Invest. 1993. PMID: 8473523 Free PMC article.
-
Role of IL-3 in the antiphospholipid syndrome.Lupus. 1994 Aug;3(4):259-61. doi: 10.1177/096120339400300410. Lupus. 1994. PMID: 7804312 Review.
-
Clinical toxicity of cytokines used as haemopoietic growth factors.Drug Saf. 1995 Dec;13(6):371-406. doi: 10.2165/00002018-199513060-00006. Drug Saf. 1995. PMID: 8652081 Review.
Cited by
-
Significant changes in the levels of secreted cytokines in brains of experimental antiphospholipid syndrome mice.Autoimmune Dis. 2012;2012:404815. doi: 10.1155/2012/404815. Epub 2012 Feb 22. Autoimmune Dis. 2012. PMID: 22454760 Free PMC article.
-
Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration.Clin Exp Immunol. 1995 Oct;102(1):120-30. doi: 10.1111/j.1365-2249.1995.tb06645.x. Clin Exp Immunol. 1995. PMID: 7554378 Free PMC article.
-
Preventing antiphospholipid antibody-induced fetal loss: a new idea.J Clin Invest. 1993 Apr;91(4):1267. doi: 10.1172/JCI116323. J Clin Invest. 1993. PMID: 8473480 Free PMC article. No abstract available.
-
Autoimmunity and recurrent pregnancy losses.Clin Rev Allergy Immunol. 2010 Dec;39(3):148-52. doi: 10.1007/s12016-009-8179-1. Clin Rev Allergy Immunol. 2010. PMID: 19842070 Review.
-
Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.J Immunol Res. 2014;2014:239398. doi: 10.1155/2014/239398. Epub 2014 Mar 13. J Immunol Res. 2014. PMID: 24741580 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources